EBS vs EW · rev $1.04B vs P/E 47, rev $1.39B
Emergent Biosolutions Inc (EBS) versus Edwards Lifesciences Corp (EW) — a side-by-side from cached financials, not a winner call.
Emergent Biosolutions Inc (EBS) is a drug manufacturers - specialty & generic company listed on US.
Edwards Lifesciences Corp (EW) is a medical devices company listed on NYSE.
Latest reported EBS revenue for 2024-12-31 was $1.04B. Net income was -$190.6M. Revenue was down 0.5% from 2023-12-31 to 2024-12-31. EBS currently screens at market cap $416.4M.
Latest reported EW revenue for 2024-12-31 was $1.39B. Net income was $385.6M. Revenue was up 2.3% from 2024-09-30 to 2024-12-31. EW currently screens at market cap $49.91B and trailing P/E 46.9.
EBS currently screens at market cap $416.4M. EW currently screens at market cap $49.91B and trailing P/E 46.9.
Not investment advice. Open the EBS and EW stock pages for the full models.
Not investment advice.